N. Leigh Anderson, Ph.D.
Chief Executive Officer
Plasma Proteome Institute
Washington, DC
www.plasmaproteome.org

Dr. Anderson obtained his B.A. with honors in physics from Yale University and his Ph.D. in molecular biology from Cambridge University. Subsequently, he co-founded (with Dr. Norman Anderson) the Molecular Anatomy Program at the Argonne National Laboratory (Chicago).

Drs. N. Leigh Anderson and Norman Anderson together undertook the first systematic "proteomics" investigations of human plasma by 2-D electrophoresis. They further analyzed plasma protein micro heterogeneity, and the properties of plasma antibodies.

Currently, Dr. N. Leigh Anderson is the founder and Chief Executive Officer of the Plasma Proteome Institute, which aims to foster the comprehensive exploration of the proteins of human blood plasma (the plasma proteome) and the rapid application of novel protein measurements in clinical diagnostics.

Dr. Anderson was previously Chief Scientific Officer at Large Scale Biology Corporation, where he founded the division of proteomics in 1985, developed the first automated two-dimensional electrophoresis technology platform for proteomics research and pioneered a range of applications in drug discovery, toxicology, and surrogate markers. He also initiated a database of plasma proteins observed by 2-D electrophoresis and a collaboration with Pfizer that provided early direct evidence of the utility of multiple plasma protein marker panels in the study of inflammation and anti-inflammatory drug effects. More recently, Dr. Anderson initiated the plasma protein proteomics program at LSBC, which successfully developed immunosubtraction processes for removal of the 10+ most abundant plasma proteins and additional chromatographic fractionation processes for uncovering minor protein constituents.

Dr. Anderson holds 15 patents, has written one book and over 120 scientific publications, mainly in the areas of proteomics and its applications.